# US 2013/0260435 A1 · Electroporation-induced electrosensitization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0260435 A1
- Document ID: US20130260435A1
- Status: Published application
- Kind: A1
- Application number: 13/994,508
- Filed: 2011-12-13
- Published: 2013-10-03
- Earliest claimed: 2010-12-15
- Assignees: Old Dominion University Research Foundation
- Inventors: Olga Pakhomova; Andrei G. Pakhomov
- Web page: https://patentgrep.com/patent/US20130260435A1

## CPC

- C12N 13/00: Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
- A61N 1/327: {for enhancing the absorption properties of tissue, e.g. by electroporation}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods of enhancing membrane permeabilization in a cell are provided. A method includes disposing the cell between a first electrode and a second electrode and applying a plurality of electrical pulses between the first electrode and the second electrode. In the method, the plurality of electrical pulses include at least two trains of pulses separated by an interval greater than about 10 s. Further, the amplitude of the electrical pulses is selected to be greater than about 0.2 kV/cm.

## Claims

### Claim 1

A method of enhancing membrane permeabilization in at least one cell, comprising:
(a) disposing the at least one cell between a first electrode and a second electrode; and
(b) applying a plurality of electrical pulses between the first electrode and the second electrode,
wherein the plurality of electrical pulses comprise at least two trains of pulses separated by an interval, and wherein an amplitude of the electrical pulses is greater than about 0.2 kV/cm.

### Claim 2 (depends on 1)

The method of claim 1, wherein a duration of time for the plurality of pulses is between about 10 s and 1000 s.

### Claim 3 (depends on 1)

The method of claim 1, wherein the amplitude is between about 0.2 kV/cm and 15 kV/cm.

### Claim 4 (depends on 1)

The method claim 1, wherein the plurality of electrical pulses comprises less than about 1500 pulses.

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The method of claim 1, wherein the interval is at least 10 s.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein the interval is between about 10 s and 30 minutes.

### Claim 10 (depends on 1)

The method of claim 1, wherein the at least two trains of pulses comprise a first train of one or more electrical pulses and a second train of one or more electrical pulses.

### Claim 11 (depends on 10)

The method of claim 10, wherein the first train and the second train are substantially the same.

### Claim 12 (depends on 10)

The method of claim 10, wherein the first train and the second train are different.

### Claim 13 (depends on 10)

The method of claim 10, wherein a number of electrical pulses in the first train comprises 25% to 75% of the plurality of electrical pulses.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The method of claim 1, wherein the at least one cell is one of a cancerous cell, a mammalian cell, a bacterial cell, or a plant cell.

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method of claim 1, further comprising introducing a therapeutic agent into the at least one cell, wherein the therapeutic agent is selected from the group consisting of: nucleic acid, peptide, polypeptide, and drug.

### Claim 20 (depends on 1)

The method of claim 1, wherein enhancing membrane permeabilization in the at least one cell results in rupturing of the membrane and in death of the at least one cell.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 1)

The method of claim 1, wherein disposing the at least one cell between the first electrode and the second electrode comprises disposing a volume of liquid including the at least one cell between the first electrode and the second electrode.

### Claim 24

A method of introducing a therapeutic agent into at least one cell, comprising:
(a) disposing the at least one cell between a first electrode and a second electrode;
(b) applying a plurality of electrical pulses between the first electrode and the second electrode; and
(c) supplying the therapeutic agent to the at least one cell;
wherein the plurality of electrical pulses comprise at least two trains of pulses separated by an interval, and wherein an amplitude of the electrical pulses is greater than about 0.2 kV/cm.

### Claim 25 (depends on 24)

The method of claim 24, wherein a duration of time for the plurality of pulses is between about 10 s and 100 s.

### Claim 26 (depends on 24)

The method of claim 24, wherein the amplitude is greater than about between about 0.2 kV/cm and 15 kV/cm.

### Claim 27 (depends on 24)

The method claim 24, wherein the plurality of electrical pulses comprises less than about 1500 pulses.

### Claim 28

(canceled)

### Claim 29 (depends on 24)

The method of claim 24, wherein the at least two trains of pulses comprise a first train of one or more electrical pulses and a second train of one or more electrical pulses.

### Claim 30 (depends on 29)

The method of claim 29, wherein the first train and the second train are substantially the same.

### Claim 31 (depends on 29)

The method of claim 29, wherein the first train and the second train are different.

### Claim 32 (depends on 29)

The method of claim 29, wherein a number of electrical pulses in the first train is different than a number of electrical pulses in the second train such that the first train comprises 25% to 75% of the plurality of electrical pulses.

### Claim 33 (depends on 24)

The method of claim 24, wherein the at least one cell is a mammalian cell.

### Claim 34 (depends on 24)

The method of claim 24, wherein the therapeutic agent is selected from the group consisting of: nucleic acid, peptide, polypeptide, and drug.
